Ravichandran Ramasamy

16.0k total citations · 3 hit papers
178 papers, 13.0k citations indexed

About

Ravichandran Ramasamy is a scholar working on Clinical Biochemistry, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Ravichandran Ramasamy has authored 178 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Clinical Biochemistry, 50 papers in Pathology and Forensic Medicine and 38 papers in Molecular Biology. Recurrent topics in Ravichandran Ramasamy's work include Advanced Glycation End Products research (77 papers), Cardiac Ischemia and Reperfusion (40 papers) and Aldose Reductase and Taurine (34 papers). Ravichandran Ramasamy is often cited by papers focused on Advanced Glycation End Products research (77 papers), Cardiac Ischemia and Reperfusion (40 papers) and Aldose Reductase and Taurine (34 papers). Ravichandran Ramasamy collaborates with scholars based in United States, Portugal and Canada. Ravichandran Ramasamy's co-authors include Ann Marie Schmidt, Shi Fang Yan, Nosirudeen Quadri, Prashant Monian, Minghui Gao, Xuejun Jiang, Radha Ananthakrishnan, Kevan C. Herold, Yoshifumi Naka and Saul Schaefer and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Ravichandran Ramasamy

177 papers receiving 12.7k citations

Hit Papers

Glutaminolysis and Transferrin Regulate Ferro... 2005 2026 2012 2019 2015 2005 2011 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Glutaminolysis and Transferrin Regulate Ferroptosis
    2015 1.6k citations Nosirudeen Quadri, Ravichandran Ramasamy et al. profile →
  2. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation
    2005 670 citations Ravichandran Ramasamy, Shi Fang Yan et al. profile →
  3. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications
    2011 393 citations Ravichandran Ramasamy, Shi Fang Yan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ravichandran Ramasamy United States 59 5.2k 4.2k 2.8k 2.3k 1.7k 178 13.0k
Toshio Miyata Japan 75 5.8k 1.1× 4.6k 1.1× 2.7k 1.0× 3.1k 1.3× 1.0k 0.6× 326 18.4k
Kumar Sharma United States 76 2.5k 0.5× 7.6k 1.8× 3.9k 1.4× 2.5k 1.1× 1.3k 0.8× 216 19.1k
Erwin Schleicher Germany 57 2.6k 0.5× 4.7k 1.1× 2.4k 0.9× 2.9k 1.2× 623 0.4× 203 12.0k
Michael Brownlee United States 35 4.3k 0.8× 4.4k 1.0× 3.3k 1.2× 3.2k 1.4× 309 0.2× 58 12.8k
Sho‐ichi Yamagishi Japan 80 10.3k 2.0× 6.0k 1.4× 7.8k 2.8× 3.8k 1.7× 1.0k 0.6× 449 23.2k
Toshimitsu Niwa Japan 60 2.5k 0.5× 4.1k 1.0× 1.5k 0.6× 1.9k 0.8× 818 0.5× 311 13.0k
Ronald G. Tilton United States 53 1.8k 0.3× 2.8k 0.6× 1.4k 0.5× 3.1k 1.3× 950 0.6× 127 10.2k
Masakazu Haneda Japan 67 1.4k 0.3× 4.8k 1.1× 5.4k 2.0× 2.3k 1.0× 827 0.5× 292 16.1k
Suzanne R. Thorpe United States 70 10.3k 2.0× 5.2k 1.2× 5.8k 2.1× 4.2k 1.8× 471 0.3× 165 19.1k
Hitoshi Endou Japan 89 4.1k 0.8× 10.9k 2.6× 1.0k 0.4× 1.2k 0.5× 1.2k 0.7× 404 26.1k

Countries citing papers authored by Ravichandran Ramasamy

Since Specialization
Citations

This map shows the geographic impact of Ravichandran Ramasamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravichandran Ramasamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravichandran Ramasamy more than expected).

Fields of papers citing papers by Ravichandran Ramasamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravichandran Ramasamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravichandran Ramasamy. The network helps show where Ravichandran Ramasamy may publish in the future.

Co-authorship network of co-authors of Ravichandran Ramasamy

This figure shows the co-authorship network connecting the top 25 collaborators of Ravichandran Ramasamy. A scholar is included among the top collaborators of Ravichandran Ramasamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravichandran Ramasamy. Ravichandran Ramasamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilson, Robin A., Michaele B. Manigrasso, Boyan Zhou, et al.. (2024). Sex differences in murine MASH induced by a fructose-palmitate-cholesterol-enriched diet. JHEP Reports. 7(2). 101222–101222. 7 indexed citations
2.
Ramasamy, Ravichandran, Alexander Shekhtman, & Ann Marie Schmidt. (2024). RAGE/DIAPH1 Axis and Cardiometabolic Disease: From Nascent Discoveries to Therapeutic Potential. Arteriosclerosis Thrombosis and Vascular Biology. 44(7). 1497–1501. 2 indexed citations
3.
Ramasamy, Ravichandran, Alexander Shekhtman, & Ann Marie Schmidt. (2023). RAGE/DIAPH1 and atherosclerosis through an evolving lens: Viewing the cell from the “Inside – Out”. Atherosclerosis. 394. 117304–117304. 4 indexed citations
4.
Cabodevilla, Ainara G., Ni-Huiping Son, Yunying Hu, et al.. (2022). Blocking Lipid Uptake Pathways Does not Prevent Toxicity in Adipose Triglyceride Lipase (ATGL) Deficiency. Journal of Lipid Research. 63(11). 100274–100274. 5 indexed citations
5.
Popp, Collin, Henry H. Ruiz, Robin A. Wilson, et al.. (2022). The RAGE/DIAPH1 axis: mediator of obesity and proposed biomarker of human cardiometabolic disease. Cardiovascular Research. 119(18). 2813–2824. 12 indexed citations
6.
López‐Díez, Raquel, et al.. (2021). Diabetes and Cardiovascular Complications: The Epidemics Continue. Current Cardiology Reports. 23(7). 74–74. 13 indexed citations
7.
López‐Díez, Raquel, Lander Egaña-Gorroño, Jian–Hua Liu, et al.. (2020). RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism. JCI Insight. 5(13). 45 indexed citations
8.
Ruiz, Henry H., Robin A. Wilson, Michaele B. Manigrasso, et al.. (2020). An Eclectic Cast of Cellular Actors Orchestrates Innate Immune Responses in the Mechanisms Driving Obesity and Metabolic Perturbation. Circulation Research. 126(11). 1565–1589. 15 indexed citations
9.
Ramasamy, Ravichandran, et al.. (2020). Journey to a Receptor for Advanced Glycation End Products Connection in Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Arteriosclerosis Thrombosis and Vascular Biology. 41(2). 614–627. 20 indexed citations
10.
Ruiz, Henry H., Ravichandran Ramasamy, & Ann Marie Schmidt. (2019). Advanced Glycation End Products: Building on the Concept of the “Common Soil” in Metabolic Disease. Endocrinology. 161(1). 136 indexed citations
11.
Yuan, Chujun, Jiyuan Hu, Saj Parathath, et al.. (2018). Human Aldose Reductase Expression Prevents Atherosclerosis Regression in Diabetic Mice. Diabetes. 67(9). 1880–1891. 18 indexed citations
12.
Thiagarajan, Devi, Gopalkrishna Sreejit, Radha Ananthakrishnan, et al.. (2017). Aldose reductase modulates acute activation of mesenchymal markers via the β-catenin pathway during cardiac ischemia-reperfusion. PLoS ONE. 12(11). e0188981–e0188981. 3 indexed citations
13.
López‐Díez, Raquel, Alexander Shekhtman, Ravichandran Ramasamy, & Ann Marie Schmidt. (2016). Cellular mechanisms and consequences of glycation in atherosclerosis and obesity. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(12). 2244–2252. 56 indexed citations
14.
Schmidt, Ann Marie, et al.. (2012). Imaging of Receptors for Advanced Glycation End Products in Experimental Myocardial Ischemia and Reperfusion Injury. JACC. Cardiovascular imaging. 5(1). 59–67. 13 indexed citations
15.
Ravindranath, Thyyar M., Phyllus Y. Mong, Radha Ananthakrishnan, et al.. (2009). Novel Role for Aldose Reductase in Mediating Acute Inflammatory Responses in the Lung. The Journal of Immunology. 183(12). 8128–8137. 42 indexed citations
16.
Guo, Jiancheng, Radha Ananthakrishnan, Wu Qu, et al.. (2008). RAGE Mediates Podocyte Injury in Adriamycin-induced Glomerulosclerosis. Journal of the American Society of Nephrology. 19(5). 961–972. 86 indexed citations
17.
Tieu, Kim, Céline Perier, Casper Caspersen, et al.. (2003). D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. Journal of Clinical Investigation. 112(6). 892–901. 357 indexed citations
18.
Hudson, Barry I., Loredana Bucciarelli, Thoralf Wendt, et al.. (2003). Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders. Archives of Biochemistry and Biophysics. 419(1). 80–88. 141 indexed citations
19.
Pinsky, David J., M. Johan Broekman, Jacques J. Peschon, et al.. (2002). Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. Journal of Clinical Investigation. 109(8). 1031–1040. 138 indexed citations
20.
Ramasamy, Ravichandran, et al.. (2000). Fructose-2,6-bisphosphate, a potent stimulator of phosphofructokinase, is increased by high exogenous glucose perfusion. Coronary Artery Disease. 11(3). 279–286. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshio Miyata Breakdown of academic impact, for papers by Kumar Sharma Breakdown of academic impact, for papers by Erwin Schleicher Breakdown of academic impact, for papers by Michael Brownlee Breakdown of academic impact, for papers by Sho‐ichi Yamagishi Breakdown of academic impact, for papers by Toshimitsu Niwa Breakdown of academic impact, for papers by Ronald G. Tilton Breakdown of academic impact, for papers by Masakazu Haneda Breakdown of academic impact, for papers by Suzanne R. Thorpe Breakdown of academic impact, for papers by Hitoshi Endou
Rankless by CCL
2026